Our programmes, informed by research, are strategically designed to test 'what works'. Alongside local partners in countries where the need is greatest we learn and refine our thinking, before sharing it through our teaching and advocacy.
Our team is informed by our development programmes and our research informs our practice. Our flagship programme AT2030 is funded by UK aid to improve access to life-changing Assistive Technology (AT) for all, investing £40m over 6 years to support solutions to scale.
AT2030 (Assistive Technology 2030) brings together partners who haven’t traditionally focused on assistive technology (AT), with experts, innovators and AT users to experiment with new ideas and thinking.
GDI Hub Academic Research Centre provides robust evidence of the effectiveness of the AT2030 projects to drive evidence and knowledge.
Over five years, AT2030 will test ‘what works’ to improve access to AT and will invest in and support solutions to scale with a focus on innovative products, new service models, and global capacity support. The programme will reach 9 million directly and 6 million more people indirectly to enable a lifetime of potential through life-changing Assistive Technology.
To address the need gap and significantly scale up the provision of affordable and appropriate Assistive Technology, this sub-programme will test market shaping methodologies which include research, scoping, and future planning; the creation of market shaping tools; and pilot testing of market interventions. This sub-programme is led by the Clinton Health Access Initiative (CHAI).